Stock Events

Stock Events

Ocumension Therapeutics 

€0.5550
0
+€0.02+3.74%Friday 15:17

Statistics

Day High
0.555
Day Low
0.545
52W High
0.95
52W Low
0.436
Volume
-
Avg. Volume
-
Mkt Cap
464.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Aug 28Expected
Q4 2025
Q2 2026
-0.02
-0.01
-0.01
-0
Expected EPS
-0.0038113732799999996
Actual EPS
-0.015245493119999998

Financials

-19.49%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
96.99MRevenue
-18.9MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Show More
CEO
Ye Liu
Employees
608
Country
China
ISIN
KYG674111011
WKN
000A2P723

Listings

STU
DE
5DG.STU
MU
DE
5DG.MU
OTC Link
US
OCUTF
F
DE
5DG.F

0 Comments

Share your thoughts

FAQs

What is Ocumension Therapeutics stock price today?▼
The current price of 5DG.STU is €0.56 EUR — it has increased by +3.74% in the past 24 hours. Watch Ocumension Therapeutics stock price performance more closely on the chart.
What is Ocumension Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Ocumension Therapeutics stocks are traded under the ticker 5DG.STU.
Is Ocumension Therapeutics stock price growing?▼
5DG.STU stock has risen by +7.77% compared to the previous week, the month change is a +0% rise, over the last year Ocumension Therapeutics has showed a -39.34% decrease.
What is Ocumension Therapeutics market cap?▼
Today Ocumension Therapeutics has the market capitalization of 464.16M
When is the next Ocumension Therapeutics earnings date?▼
Ocumension Therapeutics is going to release the next earnings report on March 19, 2027.
What were Ocumension Therapeutics earnings last quarter?▼
5DG.STU earnings for the last quarter are -0.02 EUR per share, whereas the estimation was -0 EUR resulting in a -300% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Ocumension Therapeutics revenue for the last year?▼
Ocumension Therapeutics revenue for the last year amounts to 96.99M EUR.
What is Ocumension Therapeutics net income for the last year?▼
5DG.STU net income for the last year is -18.9M EUR.
How many employees does Ocumension Therapeutics have?▼
As of November 8, 2026, the company has 608 employees.
In which sector is Ocumension Therapeutics located?▼
Ocumension Therapeutics operates in the Health & Wellness sector.
When did Ocumension Therapeutics complete a stock split?▼
Ocumension Therapeutics has not had any recent stock splits.
Where is Ocumension Therapeutics headquartered?▼
Ocumension Therapeutics is headquartered in Suzhou, China.